HanchorBio Partners with Bloomberg to Boost Pipeline & Strategy Execution
HanchorBio, Inc. , a global clinical-stage biotechnology company advancing next-generation immunotherapies for immuno-oncology and immune-related diseases, announced it has selected Bloomberg to support strategic decision-making across portfolio planning, pipeline development, competitive monitoring, business developm…
